It is also important to consult with a healthcare provider before starting B12 shots, especially for those on medications that may interfere with B12 absorption or metabolism
Benefits & Considerations Potential Benefits: Greater weight loss efficacy than single-agent GLP-1s Enhanced satiety and appetite control Reduced caloric intake without stimulant side effects Possible benefits on glucose regulation and lipids Considerations: Still experimental not yet available for clinical use May share similar GI side effects (nausea, fullness, constipation) Requires ongoing injection therapy for maintenance The Future of Multi-Hormone Obesity Therapy If current trials continue to show success, cagrilintide-based combinations could usher in a new generation of multi-agonist weight-loss medicationssimilar to how tirzepatide built on semaglutides success by adding GIP activity
GHK-Cus ability to reduce inflammation and oxidative stress further supports its potential in therapeutic applications for tissue repair
Most community protocols start cagrilintide at 0.25 mg/week once retatrutide is established, then step up every 4 weeks to 0.5, 1.0, 1.7, and 2.4 mg/week
Monitoring and Follow-Up After starting vitamin B12 injection therapy , follow-up is critical